There are a number of connected and wearable devices that are meant to track a person's health, with companies like JawBone, Nike, Adidas and Under Armour putting out their own wearable fitness trackers.
What you don't hear about as much, but I suspect you will soon, are devices that help monitor chronic diseases. With the rise in obesity in this country, the number of people with chronic illnesses is no doubt going to rise too. And plenty of people are going to want to make money off of that market.
Glooko, a creator of a tracking device that focuses on patients with diabetes, has raised $7 million in Series A-1 funding, the company has announced.
The investment came from new investors including Samsung Venture Investment Company (SVIC) and Lifeforce Ventures, as well as existing investors including The Social + Capital Partnership, Sundeep Madra and Yogen Dalal.
Glooko has now raised a total of $11.5 million. The company raised $3.5 million Series A funding from The Social+Capital Partnership, Bill Campbell, Vint Cerf, Judy Estrin and Andy Hertzfeld, Venky Harinarayan, Russell Hirsch and Xtreme Labs in January of 2012.
The company says that it be using the funding to "focus on enabling predictive diabetes care by delivering patient data and decision-making algorithms to health providers and payer groups."
That includes adding a layer of analytics and messaging capable of making therapeutic recommendations for diabetes management.
Launched at the end of 2010, Glooko is a digital logbook for people with diabetes who have to check their blood sugar every day.
Glooko makes a cable, called the MeterSync Cable, and a mobile app that is available on both iOS and Android.
The app allows patients to log medications and foods, including nutritional data on over 200,000 foods and menus from most major restaurants. Through a web dashboard that translates key blood glucose, carb and medication data into statistics and graphs, providers are better able to manage their patients with diabetes.
When the cable is combined with the Glooko’s mobile application, it allows for glucose data to be directly transferred from a glucose meter into a mobile device. The mobile apps integrates into the existing Glooko diabetes management web dashboards, which enable healthcare professionals and care management teams to remotely monitor and identify at-risk patients.
(Image source: https://www.glooko.com)